High-throughput somatic mutation profiling in pulmonary sarcomatoid carcinomas using the LungCarta™ Panel: exploring therapeutic targets
Vincent Fallet, Raphaël Saffroy, Nicolas Girard et al. · Annals of Oncology · 2015
Cited by 91 works. doi:10.1093/annonc/mdv232 Open-access PDF
Authors
- Vincent Fallet
- Raphaël Saffroy
- Nicolas Girard
- Julien Mazières
- Sylvie Lantuéjoul
- Thibault Vieira
- Isabelle Rouquette
- F. Thivolet-Béjui
- Mony Ung
- Virginie Poulot
- Laurène Schlick
- Denis Moro‐Sibilot
- Martine Antoine
- Jacques L. Cadranel
- Antoinette Lemoine
- Marie Wislez
References
- Somatic mutations affect key pathways in lung adenocarcinoma
- Pathology and genetics of tumours of the lung , pleura, thymus and heart
- High-throughput oncogene mutation profiling in human cancer
- Frequency and Distinctive Spectrum of KRAS Mutations in Never Smokers with Lung Adenocarcinoma
- Outcomes of sarcomatoid carcinoma of the lung: A Surveillance, Epidemiology, and End Results database analysis
- Rare EGFR exon 18 and exon 20 mutations in non-small-cell lung cancer on 10 117 patients: a multicentre observational study by the French ERMETIC-IFCT network
- Palliative chemotherapy for pulmonary pleomorphic carcinoma
- Efficacy of First-Line Chemotherapy in Patients with Advanced Lung Sarcomatoid Carcinoma
- Pulmonary Pleomorphic Carcinoma: A Clinicopathological Study Including EGFR Mutation Analysis
- Clinical characteristics of pleomorphic carcinoma of the lung